Separately, Zacks Investment Research lowered shares of Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Saturday, May 11th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $19.50.
Shares of WNC opened at $15.30 on Friday. Wabash National has a 12 month low of $12.25 and a 12 month high of $20.78. The stock’s 50 day simple moving average is $14.96. The company has a market capitalization of $833.06 million, a PE ratio of 10.63 and a beta of 2.02. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.80 and a quick ratio of 1.08.
Wabash National (NYSE:WNC) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. The business had revenue of $533.00 million for the quarter, compared to analysts’ expectations of $519.74 million. Wabash National had a net margin of 2.73% and a return on equity of 17.02%. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $0.28 earnings per share. As a group, sell-side analysts forecast that Wabash National will post 1.63 EPS for the current year.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. lifted its stake in shares of Wabash National by 15.5% during the 1st quarter. JPMorgan Chase & Co. now owns 3,111,767 shares of the company’s stock valued at $42,165,000 after buying an additional 417,141 shares in the last quarter. Millennium Management LLC increased its holdings in shares of Wabash National by 39.3% in the 4th quarter. Millennium Management LLC now owns 828,288 shares of the company’s stock worth $10,834,000 after buying an additional 233,893 shares during the last quarter. Royce & Associates LP increased its holdings in shares of Wabash National by 3.8% in the 1st quarter. Royce & Associates LP now owns 2,903,669 shares of the company’s stock worth $39,345,000 after buying an additional 107,094 shares during the last quarter. Nordea Investment Management AB increased its holdings in shares of Wabash National by 23.2% in the 1st quarter. Nordea Investment Management AB now owns 325,808 shares of the company’s stock worth $4,414,000 after buying an additional 61,345 shares during the last quarter. Finally, Mackay Shields LLC bought a new position in shares of Wabash National in the 4th quarter worth $700,000. Hedge funds and other institutional investors own 97.07% of the company’s stock.
About Wabash National
Wabash National Corporation designs, manufactures, and distributes transportation and diversified industrial products; and provides services primarily in the United States. The company operates through three segments: Commercial Trailer Products, Diversified Products, and Final Mile Products. The Commercial Trailer Products segment provides dry van trailers; platform trailers; refrigerated trailers; converter dollies, big tire haulers, steel coil haulers, and RoadRailer trailers; aftermarket parts and services; and used trailers.
Featured Article: How can you know how many shares are floating?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Wabash National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wabash National and related companies with MarketBeat.com's FREE daily email newsletter.